Pyrazolopyridine inhibitors of B-Raf(V600E). Part 4: rational design and kinase selectivity profile of cell potent type II inhibitors. | Bioorg Med Chem Lett;22(19): 6237-41, 2012 Oct 01. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Pyrazolopyridine inhibitors of B-Raf(V600E). Part 4: rational design and kinase selectivity profile of cell potent type II inhibitors.

Wenglowsky, Steve; Moreno, David; Laird, Ellen R; Gloor, Susan L; Ren, Li; Risom, Tyler; Rudolph, Joachim; Sturgis, Hillary L; Voegtli, Walter C.

Affiliation

Wenglowsky S; Array BioPharma, 3200 Walnut Street, Boulder, CO 80301, United States.

Bioorg Med Chem Lett ; 22(19): 6237-41, 2012 Oct 01.

Article in En | MEDLINE | ID: mdl-22954737

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrazoles / Pyridines / Drug Design / Proto-Oncogene Proteins B-raf / Protein Kinase Inhibitors Limits: Animals / Humans Language: En Journal: Bioorg Med Chem Lett Journal subject: BIOQUIMICA / QUIMICA Year: 2012 Document type: Article Affiliation country: Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrazoles / Pyridines / Drug Design / Proto-Oncogene Proteins B-raf / Protein Kinase Inhibitors Limits: Animals / Humans Language: En Journal: Bioorg Med Chem Lett Journal subject: BIOQUIMICA / QUIMICA Year: 2012 Document type: Article Affiliation country: Country of publication: